Free Trial
NASDAQ:CRON

Cronos Group (CRON) Stock Price, News & Analysis

Cronos Group logo
$2.09
-0.02 (-0.95%)
(As of 10/31/2024 ET)

About Cronos Group Stock (NASDAQ:CRON)

Key Stats

Today's Range
$2.09
$2.12
50-Day Range
$2.08
$2.34
52-Week Range
$1.72
$3.14
Volume
458,924 shs
Average Volume
1.93 million shs
Market Capitalization
$799.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00
Consensus Rating
Sell

Company Overview

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Cronos Group Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
37th Percentile Overall Score

CRON MarketRank™: 

Cronos Group scored higher than 37% of companies evaluated by MarketBeat, and ranked 795th out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cronos Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Cronos Group has received no research coverage in the past 90 days.

  • Read more about Cronos Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Cronos Group are expected to grow in the coming year, from ($0.05) to $0.01 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cronos Group is -13.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cronos Group is -13.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cronos Group has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cronos Group's valuation and earnings.
  • Percentage of Shares Shorted

    2.46% of the float of Cronos Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Cronos Group has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Cronos Group has recently decreased by 1.20%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cronos Group does not currently pay a dividend.

  • Dividend Growth

    Cronos Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.46% of the float of Cronos Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Cronos Group has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Cronos Group has recently decreased by 1.20%, indicating that investor sentiment is improving.
  • News Sentiment

    Cronos Group has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Cronos Group this week, compared to 3 articles on an average week.
  • Search Interest

    Only 3 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Cronos Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cronos Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.90% of the stock of Cronos Group is held by insiders.

  • Percentage Held by Institutions

    Only 8.71% of the stock of Cronos Group is held by institutions.

  • Read more about Cronos Group's insider trading history.
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

Spotlight On TSX Penny Stocks For October 2024
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Spinach® Is the Number One Cannabis Brand in Canada
Cronos Group Inc. (CRON): A Bull Case Theory
See More Headlines

CRON Stock Analysis - Frequently Asked Questions

Cronos Group's stock was trading at $2.09 on January 1st, 2024. Since then, CRON stock has increased by 0.0% and is now trading at $2.09.
View the best growth stocks for 2024 here
.

Cronos Group Inc. (NASDAQ:CRON) announced its quarterly earnings data on Thursday, August, 8th. The company reported ($0.02) EPS for the quarter. The business earned $27.76 million during the quarter, compared to analysts' expectations of $25.85 million. Cronos Group had a negative trailing twelve-month return on equity of 2.06% and a negative net margin of 56.43%.

Top institutional investors of Cronos Group include Intact Investment Management Inc. (0.10%) and International Assets Investment Management LLC (0.01%).
View institutional ownership trends
.

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/08/2024
Today
10/31/2024
Next Earnings (Confirmed)
11/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CRON
Fax
N/A
Employees
356
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.00
High Stock Price Target
$3.50
Low Stock Price Target
$2.50
Potential Upside/Downside
+43.5%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

Net Income
$-73,960,000.00
Pretax Margin
-61.24%

Debt

Sales & Book Value

Annual Sales
$101.78 million
Book Value
$2.87 per share

Miscellaneous

Free Float
355,917,000
Market Cap
$799.00 million
Optionable
Optionable
Beta
0.97
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:CRON) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners